New Anticancer Agents Study Findings Reported from Al-Azhar University (Design, Synthesis, Docking, Admet and Anticancer Evaluations of n-alkyl Substituted Iodoquinazoline Derivatives As Dual Vegfr-2 and Egfr Inhibitors)

MLA

“New Anticancer Agents Study Findings Reported from Al-Azhar University (Design, Synthesis, Docking, Admet and Anticancer Evaluations of n-Alkyl Substituted Iodoquinazoline Derivatives As Dual Vegfr-2 and Egfr Inhibitors).” Obesity, Fitness & Wellness Week, Jan. 2024, p. 1516. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.779982136&authtype=sso&custid=ns315887.

APA

New Anticancer Agents Study Findings Reported from Al-Azhar University (Design, Synthesis, Docking, Admet and Anticancer Evaluations of n-alkyl Substituted Iodoquinazoline Derivatives As Dual Vegfr-2 and Egfr Inhibitors). (2024, January 27). Obesity, Fitness & Wellness Week, 1516.

Chicago

Obesity, Fitness & Wellness Week. 2024. “New Anticancer Agents Study Findings Reported from Al-Azhar University (Design, Synthesis, Docking, Admet and Anticancer Evaluations of n-Alkyl Substituted Iodoquinazoline Derivatives As Dual Vegfr-2 and Egfr Inhibitors),” January 27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.779982136&authtype=sso&custid=ns315887.